Known safety concerns, contraindications, and risk factors.
Cerebrolysin is not FDA-approved, is parenteral-only, and carries a documented serious-adverse-event signal. Nothing here is medical advice or a recommendation to use it. Clinical supervision is essential.
Porcine allergy / hypersensitivity
Absolute contraindication due to anaphylaxis risk.
Epilepsy or seizure disorders
Contraindicated in epilepsy, status epilepticus, or increasing seizure frequency.
Severe renal impairment (GFR < 15 mL/min)
Contraindicated in kidney failure or severe renal impairment.
Pregnancy and breastfeeding
Not recommended; no human safety data despite non-teratogenic animal studies.
Antidepressants / MAO inhibitors (e.g. phenelzine)
Interaction may amplify side effects.